Meine Merkliste  

2.701 Aktuelle Fachpublikationen von Future Medicine


Differential diagnostic assays for discriminating mycobacteria, especially for nontuberculous mycobacteria: what does the future hold?

17.02.2015 | Yoshihiko Hoshino; Koichi Suzuki, Future Microbiology, 2015

ABSTRACT Mycobacteria infections are an important medical problem, and many are regarded as emerging and re-emerging diseases. Mycobacterium tuberculosis, the causative agent of tuberculosis, remains a leading cause of human morbidity and mortality worldwide, with approximately 8.6 million cases ...


Crohn's disease therapy with Dietzia: the end of anti-inflammatory drugs

17.02.2015 | Robert E Click, Future Microbiology, 2015

Future Microbiology February 2015, Vol. 10, No. 2, Pages 147-150.


Low-level laser therapy as an antimicrobial and antibiofilm technology and its relevance to wound healing

17.02.2015 | Steven L Percival; Iolanda Francolini; Gianfranco Donelli, Future Microbiology, 2015

ABSTRACT The biostimulative effect of low-level laser therapy (LLLT) in tissues has been noted in reference to the treatment of various diseases but little information exists on its effectiveness on chronic wounds and biofilm. The scope of this review was to identify literature reporting on LLLT ...


Melioidosis in Africa: should we be looking more closely?

17.02.2015 | Emma Birnie; Willem J Wiersinga; Direk Limmathurotsakul; Martin P Grobusch, Future Microbiology, 2015

ABSTRACT Melioidosis is a life-threatening infection caused by the Gram-negative bacterium Burkholderia pseudomallei, mainly found in Southeast Asia. Recently, African foci have been identified, although reports remain mostly anecdotal. In Africa, multiple febrile diseases have been erroneously ...


Effects of hyperbaric oxygen on Pseudomonas aeruginosa susceptibility to imipenem and macrophages

17.02.2015 | Flavia Luna Lima; Paulo Pinto Joazeiro; Marcelo Lancellotti; Luciana Maria de Hollanda; Bruna de Araújo Lima; Edlain ..., Future Microbiology, 2015

ABSTRACT Background: The seriousness to treat burn wounds infected with Pseudomonas aeruginosa led us to examine whether the effect of the carbapenem antibiotic imipenem is enhanced by hyperbaric oxygen (HBO). Materials & methods: The effects of HBO (100% O2, 3 ATA, 5 h) in combination with ...


Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections

17.02.2015 | Matteo Bassetti; Elda Righi, Future Microbiology, 2015

ABSTRACT High rates of morbidity and mortality have been linked to the emergence of antimicrobial-resistant Gram-negative pathogens, especially in the hospital setting. Infections due to extended-spectrum-β-lactamase producing Enterobacteriaceae (e.g., Escherichia coli, Klebsiella pneumoniae) ...


Impact of risk stratification on the duration of caspofungin therapy for invasive fungal disease in acute leukemic patients

17.02.2015 | Wei Li; Xingli Zhao; Benfa Gong; Yuntao Liu; Shuning Wei; Guangji Zhang; Kaiqi Liu; Bingcheng Liu; Hui Wei; Ying Wan ..., Future Microbiology, 2015

ABSTRACT Aim: We retrospectively analyzed 141 acute leukemia patients with unclassified invasive fungal disease episodes during chemotherapy to determine the optimum duration of antifungal treatment. Patients & methods: Patients were divided into standard-risk and high-risk groups and treated ...


Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda

17.02.2015 | Francesco G De Rosa; Silvia Corcione; Rossana Cavallo; Giovanni Di Perri; Matteo Bassetti, Future Microbiology, 2015

ABSTRACT The wide dissemination of carbapenemase producing K. pneumoniae (KPC-Kp) has caused a public health crisis of global dimensions, due to the serious infections in hospitalized patients associated with high mortality. In 2014, we aim to review clinical data on KPC-Kp at a time when a ...


Microscale microbial culture

17.02.2015 | Anand Srinivasan; Jose L Lopez-Ribot; Anand K Ramasubramanian, Future Microbiology, 2015

Future Microbiology February 2015, Vol. 10, No. 2, Pages 143-146.


The future for early-stage tuberculosis drug discovery

17.02.2015 | Edison S Zuniga; Julie Early; Tanya Parish, Future Microbiology, 2015

ABSTRACT There is an urgent need for new and better drugs to treat tuberculosis due to lengthy and complex treatment regimens and a rising problem of drug resistance. Drug discovery efforts have increased over the past few years, with a larger focus on modern high-throughput screening ...


Seite 2 von 271
Suche per e-Mail abonnieren

Sie erhalten passend zu Ihrer Suche die neusten Suchergebnisse per E-Mail. Dieser Service ist für Sie kostenlos und kann jederzeit abbestellt werden.

Ihr Bowser ist nicht aktuell. Microsoft Internet Explorer 6.0 unterstützt einige Funktionen auf Chemie.DE nicht.